Clinical Trials
43 trialsTraveraRTGx
Travera Inc
EARN
Washington University School of Medicine
ORPHEUS
MedSIR
PEVOsq
UNICANCER
ROOT
Taproot Health
A Chatbot Intervention for Reducing HPV Vaccine Hesitancy
University of Maryland, College Park
Safety, Tolerability and Pharmacokinetics Investigation of Stimotimagene Copolymerplasmid
Gene Surgery LLC
GLANS
University Medical Center Groningen
Evaluate the Safety and Immunogenicity of a 9-valent HPV Vaccine in Chinese Healthy Male Aged 9-45 Year-old
Shanghai Bovax Biotechnology Co., Ltd.
A Message Framing Intervention for Increasing Parental Acceptance of Human Papillomavirus Vaccination
University of Maryland, College Park
HERCULES
Latin American Cooperative Oncology Group
AcSĂ©
UNICANCER
HARE-40
University of Southampton
A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies
Deciphera Pharmaceuticals, LLC
PERICLES
The Netherlands Cancer Institute
Inguinal Lymphadenectomy for Penile Cancer
A.O.U. CittĂ della Salute e della Scienza
M7824 in Subjects With HPV Associated Malignancies
National Institutes of Health Clinical Center (CC)
DUET-2
Xencor, Inc.
JAVA-P
University Hospitals Bristol and Weston NHS Foundation Trust
INFLUENCE
The Netherlands Cancer Institute
TIP (Paclitaxel + Ifosfamide + Cisplatin) Combined With Nimotuzumab & Triprilimab as Neoadjuvant Treatment in Locally Advanced Penile Cancer
Sun Yat-sen University
CaptHPV
Institut de Cancérologie de Lorraine
HER-Uro01
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Vaccine Therapy in Preventing Human Papillomavirus Infection in Young HIV-Positive Male Patients Who Have Sex With Males
AIDS Malignancy Consortium
VinCaP
Institute of Cancer Research, United Kingdom
Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions
Abramson Cancer Center at Penn Medicine
Integrating a Health Information Technology System for Primary and Secondary Cervical Cancer Prevention
Boston Medical Center
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Human Papillomavirus-Associated Cancers
National Institutes of Health Clinical Center (CC)
T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers
National Institutes of Health Clinical Center (CC)
Cancer in Patients With Gabapentin (GPRD)
GlaxoSmithKline
VICORYX-2
Oryx GmbH & Co. KG
Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer
Alliance for Clinical Trials in Oncology
Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma
Regeneron Pharmaceuticals
Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma
Regeneron Pharmaceuticals
OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer
OHSU Knight Cancer Institute
Videoscopic Versus Open Inguinal Lymphadenectomy for Cancer
Emory University
Vaccine Therapy in Treating Patients With Advanced or Recurrent Cancer
National Cancer Institute (NCI)
Early Intervention vs. Standard Palliative Care in Improving End-of-Life Care in Advanced Cancer Patients
Dartmouth-Hitchcock Medical Center
Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain
INSYS Therapeutics Inc
Irinotecan and Cisplatin in Treating Patients With Locally Advanced or Metastatic Penile Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Neoadjuvant Chemotherapy for Patients With Squamous Cell Carcinoma of the Penis
M.D. Anderson Cancer Center
MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma
National Institutes of Health Clinical Center (CC)
Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancer
Hoag Memorial Hospital Presbyterian